Aktien aus dem Gesundheitswesen
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12 |  LLY Eli Lilly and Company Common Stock | 1178.70 USD | +0.75% | +2.41% | +3.20% | +42.01% | 1.11 T USD | ||
| 20 |  JNJ Johnson & Johnson Common Stock | 261.49 USD | +1.95% | +2.30% | -3.47% | +37.87% | 630.16 B USD | ||
| 24 |  ABBV AbbVie Inc. Common Stock | 276.48 USD | +1.49% | +5.53% | +4.84% | +20.21% | 488.57 B USD | ||
| 35 |  MRK Merck & Company, Inc. Common Stock | 145.57 USD | +2.23% | +1.58% | -0.84% | +69.96% | 359.15 B USD | ||
| 38 |  UNH UnitedHealth Group Incorporated Common Stock (DE) | 379.28 USD | +2.31% | +1.87% | -0.39% | +6.97% | 340.44 B USD | ||
| 48 |  NVS Novartis AG | 143.77 USD | +0.45% | +2.01% | +1.50% | +10.93% | 274.33 B USD | ||
| 60 |  TMO Thermo Fisher Scientific Inc Common Stock | 657.76 USD | +0.92% | +1.50% | +7.07% | +25.09% | 243.20 B USD | ||
| 65 |  AMGN Amgen Inc. - Common Stock | 414.87 USD | +1.82% | +3.97% | +8.34% | +42.29% | 224.29 B USD | ||
| 78 |  GILD Gilead Sciences, Inc. - Common Stock | 151.17 USD | +2.77% | +5.56% | +3.85% | +30.21% | 187.44 B USD | ||
| 84 |  ABT Abbott Laboratories Common Stock | 99.60 USD | +1.13% | +1.63% | -4.23% | -24.55% | 172.35 B USD | ||
| 95 |  PFE Pfizer, Inc. Common Stock | 28.27 USD | +1.58% | +2.24% | +0.68% | +14.04% | 161.13 B USD | ||
| 100 |  DHR Danaher Corporation Common Stock | 219.85 USD | +1.10% | +2.73% | +9.37% | +8.27% | 154.55 B USD | ||
| 104 |  ISRG Intuitive Surgical, Inc. - Common Stock | 423.96 USD | +2.06% | +8.77% | +13.40% | -1.97% | 149.78 B USD | ||
| 118 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 510.08 USD | +1.36% | +1.25% | -2.32% | +26.23% | 129.29 B USD | ||
| 128 |  BMY Bristol-Myers Squibb Company Common Stock | 59.11 USD | -0.76% | -1.17% | -9.09% | +35.14% | 120.74 B USD | ||
| 136 |  MDT Medtronic plc. Ordinary Shares | 88.47 USD | +0.87% | +2.37% | -4.78% | -5.71% | 113.17 B USD | ||
| 138 |  CVS CVS Health Corporation Common Stock | 86.17 USD | -1.88% | -0.68% | -9.68% | +11.16% | 110.21 B USD | ||
| 139 |  MCK McKesson Corporation Common Stock | 938.77 USD | +0.89% | +3.62% | +4.84% | +16.98% | 109.45 B USD | ||
| 144 |  SYK Stryker Corporation Common Stock | 277.32 USD | +0.10% | +0.50% | -1.19% | -23.85% | 106.37 B USD | ||
| 159 |  GSK GSK plc American Depositary Shares | 46.50 USD | -0.04% | -0.58% | -7.54% | +6.04% | 100.33 B USD |
Nachrichten Aktien aus dem Gesundheitswesen
Mirum Pharmaceuticals gibt Ergebnisse der Phase-3-Studie zu LIVMARLI bekannt
BridgeBio legt positive Phase-3-Studiendaten für Encaleret vor
Alnylam-Manager verkauft Aktien im Wert von knapp 400.000 US-Dollar
Neogen-CEO Mikheal Nassif kauft Unternehmensaktien für 6.034 US-Dollar
Pacira BioSciences: Top-Managerin verkauft Aktienpaket nach starkem Kursanstieg
Cytokinetics: Top-Manager verkauft Aktien im Wert von 214.830 $
Zymeworks-Führungskraft verkauft Aktien im Wert von 357.557 $
Gainers Aktien aus dem Gesundheitswesen
 ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.73 | +50.43% |
 PDSB PDS Biotechnology Corporation - Common Stock | 1.38 | +35.29% |
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
 NXGL NexGel, Inc - Common Stock | 0.20 | +33.33% |
 BEATW Heartbeam, Inc. - Warrant | 0.0129 | +26.47% |
 QSI Quantum-Si Incorporated - Class A Common Stock | 1.53 | +25.41% |
 CUE Cue Biopharma, Inc. - Common Stock | 27.66 | +23.87% |
 NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.25 | +23.63% |
Losers Aktien aus dem Gesundheitswesen
 SXTC China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | 0.15 | -55.88% |
 MLEC Moolec Science SA - Ordinary Shares | 2.20 | -47.49% |
 PRENW Prenetics Global Limited - Warrant | 0.0082 | -24.77% |
 XRTX XORTX Therapeutics Inc. - Common Shares | 1.41 | -23.78% |
 SBFMW Sunshine Biopharma Inc. - Warrant | 0.0300 | -23.08% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0252 | -21.00% |
 SBFM Sunshine Biopharma Inc. - Common stock | 0.34 | -20.93% |
 BFRIW Biofrontera Inc. - Warrants | 0.0056 | -20.00% |